Sapient Capital LLC Reduces Stake in Liquidia Technologies, Inc. $LQDA

Sapient Capital LLC lowered its stake in Liquidia Technologies, Inc. (NASDAQ:LQDA - Free Report) by 38.0% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 75,750 shares of the company's stock after selling 46,450 shares during the period. Sapient Capital LLC owned approximately 0.09% of Liquidia Technologies worth $944,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Goldman Sachs Group Inc. boosted its holdings in shares of Liquidia Technologies by 10.7% in the 1st quarter. Goldman Sachs Group Inc. now owns 861,231 shares of the company's stock worth $12,703,000 after purchasing an additional 82,955 shares during the period. Boothbay Fund Management LLC boosted its stake in Liquidia Technologies by 18.7% during the first quarter. Boothbay Fund Management LLC now owns 662,873 shares of the company's stock worth $9,777,000 after buying an additional 104,215 shares during the period. Adage Capital Partners GP L.L.C. boosted its stake in shares of Liquidia Technologies by 446.7% during the 1st quarter. Adage Capital Partners GP L.L.C. now owns 461,248 shares of the company's stock worth $6,803,000 after purchasing an additional 376,872 shares during the period. Woodline Partners LP boosted its stake in shares of Liquidia Technologies by 1.6% during the 4th quarter. Woodline Partners LP now owns 421,683 shares of the company's stock worth $4,959,000 after purchasing an additional 6,791 shares during the period. Finally, Two Sigma Investments LP boosted its stake in shares of Liquidia Technologies by 21.4% during the 4th quarter. Two Sigma Investments LP now owns 381,237 shares of the company's stock worth $4,483,000 after purchasing an additional 67,134 shares during the period. Hedge funds and other institutional investors own 64.54% of the company's stock.

Analyst Upgrades and Downgrades

LQDA has been the subject of a number of recent analyst reports. Bank of America dropped their price target on shares of Liquidia Technologies from $25.00 to $23.00 and set a "buy" rating for the company in a research note on Wednesday, June 11th. Wells Fargo & Company boosted their target price on Liquidia Technologies from $25.00 to $31.00 and gave the company an "overweight" rating in a research report on Wednesday, August 13th. Scotiabank boosted their price objective on Liquidia Technologies from $36.00 to $37.00 and gave the company a "sector outperform" rating in a report on Wednesday, May 28th. Jefferies Financial Group began coverage on Liquidia Technologies in a report on Friday, August 15th. They set a "buy" rating and a $43.00 price objective for the company. Finally, BTIG Research reissued a "buy" rating on shares of Liquidia Technologies in a research note on Tuesday, May 27th. Two analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and one has given a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Buy" and a consensus price target of $32.11.

Liquidia Technologies Trading Down 4.0%

NASDAQ:LQDA opened at $25.00 on Thursday. Liquidia Technologies, Inc. has a 52 week low of $9.68 and a 52 week high of $29.94. The firm has a 50 day moving average of $22.71 and a 200 day moving average of $17.38. The company has a quick ratio of 2.41, a current ratio of 2.49 and a debt-to-equity ratio of 9.84. The stock has a market capitalization of $2.15 billion, a price-to-earnings ratio of -14.71 and a beta of 0.22.

Liquidia Technologies (NASDAQ:LQDA - Get Free Report) last issued its quarterly earnings data on Tuesday, August 12th. The company reported ($0.49) EPS for the quarter, missing the consensus estimate of ($0.43) by ($0.06). Liquidia Technologies had a negative net margin of 732.17% and a negative return on equity of 232.96%. The business had revenue of $8.84 million for the quarter, compared to analysts' expectations of $3.90 million. The company's revenue was up 141.5% on a year-over-year basis. As a group, sell-side analysts anticipate that Liquidia Technologies, Inc. will post -1.51 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, insider Rajeev Saggar sold 20,000 shares of the stock in a transaction that occurred on Thursday, August 28th. The shares were sold at an average price of $27.85, for a total value of $557,000.00. Following the completion of the transaction, the insider directly owned 249,727 shares of the company's stock, valued at $6,954,896.95. This trade represents a 7.41% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Paul B. Manning sold 328,268 shares of the stock in a transaction that occurred on Tuesday, September 2nd. The shares were sold at an average price of $28.78, for a total transaction of $9,447,553.04. Following the completion of the transaction, the director directly owned 430,828 shares of the company's stock, valued at $12,399,229.84. The trade was a 43.24% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 881,097 shares of company stock valued at $23,689,864 in the last 90 days. 26.50% of the stock is owned by insiders.

Liquidia Technologies Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).

Want to see what other hedge funds are holding LQDA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Liquidia Technologies, Inc. (NASDAQ:LQDA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.